Wednesday, July 8, 2026

pharma · Ovarian Cancer · Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer · ANIX

Anixa Biosciences

News and analysis for Anixa Biosciences on NovaPharmaNews — regulatory, clinical, and market coverage.

San Jose, USA HQ
1982 Founded
12 Employees
Public company Type
ANIX · NYSE Ticker
Company details
Status
Public
HQ
San Jose, USA
Founded
1982
Employees
12
Programs
2
Drugs
4
Patents
1
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Anixa Biosciences — regulatory, clinical, and market coverage.

News and analysis for Anixa Biosciences on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Anixa Biosciences yet.

Back to company overview →